These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia. Kasabian NG, Vlachiotis JD, Lais A, Klumpp B, Kelly MD, Siroky MB, Bauer SB. J Urol; 1994 Apr; 151(4):944-5. PubMed ID: 8126833 [Abstract] [Full Text] [Related]
29. Persistence of detrusor hyperreflexia in a continent, institutionalized elderly patient with Parkinson's disease. Starer P, Libow LS. N Y State J Med; 1991 Apr; 91(4):166-7. PubMed ID: 2047037 [No Abstract] [Full Text] [Related]
33. Clinical efficacy of oxybutynin on sensory urgency as compared with that on motor urgency. Hashimoto K, Ohnishi N, Esa A, Sugiyama T, Park Y, Kurita T. Urol Int; 1999 Apr; 62(1):12-6. PubMed ID: 10436424 [Abstract] [Full Text] [Related]
37. Does oxybutynin add to the effectiveness of prompted voiding for urinary incontinence among nursing home residents? A placebo-controlled trial. Ouslander JG, Schnelle JF, Uman G, Fingold S, Nigam JG, Tuico E, Jensen BB. J Am Geriatr Soc; 1995 Jun; 43(6):610-7. PubMed ID: 7775717 [Abstract] [Full Text] [Related]
39. Tethered cord syndrome in an adult. Pharmacological treatment of the urological symptomatology by oxybutynin. De Angelis M, Martina G, Caverni L, Coglitore A, Libanori GP, Giannotti P. Acta Urol Belg; 1986 Jun; 54(1):99-105. PubMed ID: 3962800 [No Abstract] [Full Text] [Related]